Álvaro Santos‐Laso

机构：Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla · ORCID：0000-0001-9810-4913

发表论文 62 篇 · 总被引 2419 次 · h-index 23

代表论文

• Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry (2022 · Journal of Hepatology · 被引 364)
• The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma (2021 · EBioMedicine · 被引 85)
• Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD (2021 · Frontiers in Medicine · 被引 67)
• miR ‐21‐5p promotes NASH ‐related hepatocarcinogenesis (2023 · Liver International · 被引 50)
• Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy? (2021 · Liver Cancer · 被引 43)
• Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets (2021 · Biomedicines · 被引 31)